Phibro Animal Health Corporation Class A (PAHC) is a publicly traded Healthcare sector company. As of October 28, 2026, PAHC trades at $38.08 with a market cap of $1.56B and a P/E ratio of 15.08. PAHC moved -1.29% today. Year to date, PAHC is +1.55%; over the trailing twelve months it is -9.12%. Its 52-week range spans $16.16 to $60.08. Analyst consensus is neutral with an average price target of $45.00. Rallies surfaces PAHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PAHC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $38.08 |
| Market Cap | $1.56B |
| P/E Ratio | 15.08 |
| EPS | $2.46 |
| Dividend Yield | 0.12% |
| 52-Week High | $60.08 |
| 52-Week Low | $16.16 |
| Volume | 124.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.52B |
| Net Income | $99.72M |
| Gross Margin | 33.76% |
2 analysts cover PAHC: 0 strong buy, 1 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $45.00.